Source credit: PubMed PMID 42364709, Journal of Pediatric and Adolescent Gynecology. DOI: 10.1016/j.jpag.2026.06.017. Published June 28, 2026.
What happened
A new commentary in the Journal of Pediatric and Adolescent Gynecology reviews the growing use of GLP-1 receptor agonists in adolescents for obesity and type 2 diabetes, while flagging unanswered questions around bone accrual, reproductive outcomes, endocrine development, and disordered-eating risk.
The authors note that adolescent trials of liraglutide and semaglutide have shown weight reduction without short-term growth or puberty signals, but they also emphasize that adolescence is a key window for building peak bone mass. They argue that longer-term monitoring is still needed, especially when rapid weight loss, appetite suppression, body-image pressure, and future pregnancy considerations may overlap.
Why it matters for lifters
For teen athletes and young lifters, the gym context matters because the paper specifically points to resistance exercise as one part of a more careful clinical picture. The takeaway is not that training cancels out medication risk, or that anyone should start, stop, or change a prescription. It is that weight-management care for adolescents should account for strength training, bone health, nutrition quality, mental health, and qualified medical supervision instead of treating scale weight as the only outcome.
What to watch next
Watch for longer follow-up studies in adolescents that track bone mineral density, lean mass, menstrual and reproductive outcomes, eating-disorder screening, and whether structured resistance training changes risk markers during medically supervised GLP-1 treatment. Adult weight-loss data and short adolescent trials are useful, but they do not answer every question for growing athletes.
Health note: This article is informational and is not medical advice. GLP-1 medications, adolescent weight-management care, eating-disorder screening, pregnancy counseling, and training decisions should be handled with qualified medical and mental-health professionals.